Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 11/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23655327 | 0.84 | PDK2 (0.61) | PDK2MAPTSMN1; SMN2L3MBTL1NPC1 | |
| SCHEMBL19172293 | 0.82 | KDM4E (0.38) | PDK2MAPTSMN1; SMN2LMNAKDM4E | |
| SCHEMBL21064480 | 0.80 | PDK2 (0.48) | PDK2MAPTSMN1; SMN2LMNAKDM4E | |
| SCHEMBL18392094 | 0.77 | KDM4E (0.39) | PDK2MAPTSMN1; SMN2LMNAKDM4E | |
| SCHEMBL19092436 | 0.77 | PDK2 (0.54) | PDK2MAPTSMN1; SMN2L3MBTL1NPC1 | |
| SCHEMBL29683736 | 0.75 | PDK2 (0.51) | PDK2MAPTSMN1; SMN2L3MBTL1NPC1 | |
| SCHEMBL24406592 | 0.74 | PDK2 (0.51) | PDK2MAPTSMN1; SMN2L3MBTL1NPC1 | |
| SCHEMBL21064459 | 0.74 | PDK2 (0.44) | PDK2MAPTSMN1; SMN2L3MBTL1NPC1 | |
| SCHEMBL19494816 | 0.73 | PDK2 (0.46) | PDK2MAPTSMN1; SMN2L3MBTL1NPC1 | |
| SCHEMBL12559993 | 0.72 | PDK2 (0.49) | PDK2MAPTSMN1; SMN2L3MBTL1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10312459-B2 | Compound and organic electronic device using the same | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2019-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10312459-B2 | Compound and organic electronic device using the same | OR51E2, OR10J3, ESR1 | PDK2 1279/4885MAPT 3328/4885SMN1; SMN2 3947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.